Prominent LGBTQ organizations that push so-called gender-affirming care for children have yet to weigh in on the news this week that England is banning puberty blockers as treatment for children experiencing gender dysphoria.
England’s National Health Service declared that there is not enough evidence of “safety and clinical effectiveness” for children and young people to take puberty blockers to treat gender dysphoria.
“Puberty blockers (gonadotrophin-releasing hormone analogues) are not available to children and young people for gender incongruence or gender dysphoria because there is not enough evidence of safety and clinical effectiveness,” the NHS notes on its site.
The announcement is a major development in the battle over gender ideology and its effects on children. Proponents of protecting children from irreversible surgeries have praised…
